← Leaderboards
D. Lansing Taylor
Carnegie-Mellon University
$26,434,637
Attributed
$37,924,540
Total exposure
14
Grants
11
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $6.6M · FY2012–25$10M$7.5M$5M$2.5M$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$41,026,712 · 15
By mechanism
UH3$15,207,188 · 3
U01$8,748,098 · 2
UG3$3,856,326 · 2
U2C$3,102,172 · 1
U24$2,981,808 · 1
R01$2,719,503 · 1
Top collaborators
- Alejandro Soto-Gutierrez7 shared
- Jaideep Behari5 shared
- William L Murphy5 shared
- John Peter Wikswo5 shared
- Mark E Schurdak4 shared
- Brion Daryl Sarachan3 shared
- Martin L Yarmush3 shared
- Srinivas Chakra Chennubhotla2 shared
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsLiverBasePharmaceutical PreparationsHepatic Acinus StructureHepatocyte3-DimensionalEngineeringMicrophysiology SystemIn VitroCell TypeAnimal ModelDisease ModelResponseEndothelial CellsInduced Pluripotent Stem CellClinical DataHeterogeneityTissuesDrug DevelopmentOrganMetabolicPharmacologic SubstanceDesign
Grant awards (44)
Qualification of Patient-Derived Biomimetic Liver MPS as Drug Discovery Tools for Drug Metabolism, Toxicity, Drug Efficacy Testing and Clinical Trial Cohort Selection$1,540,258
U2C · FY2025 · TR
Qualification of Patient-Derived Biomimetic Liver MPS as Drug Discovery Tools for Drug Metabolism, Toxicity, Drug Efficacy Testing and Clinical Trial Cohort Selection$1,561,914
U2C · FY2024 · TR
A vascularized patient-derived iPSC liver acinus microphysiology system as an innovative precision medicine platform for optimizing clinical trial design for nonalcoholic fatty liver disease$777,501
UH3 · FY2024 · TR · contact PI
A vascularized patient-derived iPSC liver acinus microphysiology system as an innovative precision medicine platform for optimizing clinical trial design for nonalcoholic fatty liver disease$762,142
UH3 · FY2023 · TR · contact PI
Human Microphysiology Systems Disease Model of Type 2 Diabetes Starting with Liver and pancreatic Islets$2,197,153
UH3 · FY2022 · DK · contact PI
Harnessing human brain and liver microphysiological systems for testing therapeutics for metastatic melanoma$1,492,261
U01 · FY2022 · TR
Development and Commercialization of the Microphysiological Systems Database as a Sustainable Resource$1,481,809
U24 · FY2022 · TR
A vascularized patient-derived iPSC liver acinus microphysiology system as an innovative precision medicine platform for optimizing clinical trial design for nonalcoholic fatty liver disease$767,285
UH3 · FY2022 · TR · contact PI
Human Microphysiology Systems Disease Model of Type 2 Diabetes Starting with Liver and pancreatic Islets$2,127,526
UH3 · FY2021 · DK · contact PI
Harnessing human brain and liver microphysiological systems for testing therapeutics for metastatic melanoma$1,510,763
U01 · FY2021 · TR
Development and Commercialization of the Microphysiological Systems Database as a Sustainable Resource$1,499,999
U24 · FY2021 · TR
A vascularized patient-derived iPSC liver acinus microphysiology system as an innovative precision medicine platform for optimizing clinical trial design for nonalcoholic fatty liver disease$791,956
UG3 · FY2021 · TR · contact PI
Applying a Human Liver Microphysiology System to Develop Therapeutic Strategies for Non-Alcoholic Fatty Liver Disease (NAFLD)$662,067
R01 · FY2021 · DK · contact PI
Human Microphysiology Systems Disease Model of Type 2 Diabetes Starting with Liver and pancreatic Islets$2,133,247
UH3 · FY2020 · DK · contact PI
Harnessing human brain and liver microphysiological systems for testing therapeutics for metastatic melanoma$1,536,934
U01 · FY2020 · TR
Opera Phenix High-Content Imaging System for Drug Discovery$1,010,594
S10 · FY2020 · OD · contact PI
A vascularized patient-derived iPSC liver acinus microphysiology system as an innovative precision medicine platform for optimizing clinical trial design for nonalcoholic fatty liver disease$748,638
UG3 · FY2020 · TR · contact PI
Applying a Human Liver Microphysiology System to Develop Therapeutic Strategies for Non-Alcoholic Fatty Liver Disease (NAFLD)$674,545
R01 · FY2020 · DK · contact PI
Human Microphysiology Systems Disease Model of Type 2 Diabetes Starting with Liver and pancreatic Islets$285,775
UH3 · FY2020 · DK · contact PI
Harnessing human brain and liver microphysiological systems for testing therapeutics for metastatic melanoma$1,530,740
U01 · FY2019 · TR
Human Microphysiology Systems Disease Model of Type 2 Diabetes Starting with Liver and pancreatic Islets$1,143,103
UG3 · FY2019 · DK · contact PI
Applying a Human Liver Microphysiology System to Develop Therapeutic Strategies for Non-Alcoholic Fatty Liver Disease (NAFLD)$685,914
R01 · FY2019 · DK · contact PI
Harnessing human brain and liver microphysiological systems for testing therapeutics for metastatic melanoma$1,571,990
U01 · FY2018 · TR
Human Microphysiology Systems Disease Model of Type 2 Diabetes Starting with Liver and pancreatic Islets$1,172,629
UG3 · FY2018 · DK · contact PI
Applying a Human Liver Microphysiology System to Develop Therapeutic Strategies for Non-Alcoholic Fatty Liver Disease (NAFLD)$696,977
R01 · FY2018 · DK · contact PI
Informatics Tools for Tumor Heterogeneity in Multiplexed Fluorescence Images$355,434
U01 · FY2018 · CA · contact PI
Chemical Biology Facility$75,374
P30 · FY2018 · CA · contact PI
Chemical Biology Facility$8,612
P30 · FY2018 · CA · contact PI
Chemical Biology Facility$3,973
P30 · FY2018 · CA · contact PI
Informatics Tools for Tumor Heterogeneity in Multiplexed Fluorescence Images$365,621
U01 · FY2017 · CA
Chemical Biology Facility$75,374
P30 · FY2017 · CA · contact PI
A 3D biomimetic liver sinusoid construct for predicting physiology and toxicity$1,821,017
UH3 · FY2016 · TR · contact PI
Informatics Tools for Tumor Heterogeneity in Multiplexed Fluorescence Images$384,355
U01 · FY2016 · CA
Creating models of rare childhood liver diseases using the human, liver-on-a-chip$154,000
UH3 · FY2016 · TR · contact PI
Chemical Biology Facility$75,746
P30 · FY2016 · CA · contact PI
A 3D biomimetic liver sinusoid construct for predicting physiology and toxicity$1,850,825
UH3 · FY2015 · TR · contact PI
Measuring the Temporal-Spatial Responses of Dormancy and Drug Resistance in a Human Breast Cancer Metastatic Niche within a Liver-on-a-Chip Microphysiological Platform$231,000
UH3 · FY2015 · TR · contact PI
Chemical Biology Facility$74,607
P30 · FY2015 · CA · contact PI
A 3D biomimetic liver sinusoid construct for predicting physiology and toxicity$2,099,717
UH3 · FY2014 · TR · contact PI
A 3D biomimetic liver sinusoid construct for predicting physiology and toxicity$1,046,286
UH2 · FY2013 · TR · contact PI
InCell 6000 High Content Instrument for Cellular Systems Biology Program$502,020
S10 · FY2013 · OD · contact PI
Collaborations to Extend the Microphysiology Database for Multiple Organ Models,$176,375
UH2 · FY2013 · TR · contact PI
A 3D biomimetic liver sinusoid construct for predicting physiology and toxicity$1,105,720
UH2 · FY2012 · TR · contact PI
STRUCTURAL AND CHEMICAL DYNAMICS OF CELL MOVEMENT$256,936
R37 · FY2000 · AR